Telomir Pharmaceuticals sells 1.1M shares in block sales, raises ~$2.9M

Telomir Pharmaceuticals, Inc.

Sold 1,100,000 shares at avg price $2.6045 (premium to prior close) to institutional investors.
Gross proceeds ~$2.9M; trades facilitated via Rodman & Renshaw on StockBlock platform.
No warrants issued; offering conducted through existing ATM equity facility.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.